Ketamine

Cardiovascular

4 drugs in development·3 companies·2 clinical trials

Drug Pipeline by Phase

Phase 3(3)

Drug	Company
tak-063	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-063	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-063	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)

N/A(1)

Drug	Company
Ketamine	Valneva SE (VALN)

BioSniper tracks 4 drugs in development for Ketamine across 3 companies.

There are 2 clinical trials targeting Ketamine tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.